Flow Cytometry Market worth $3.7 Billion in 2018

Tuesday 13 May 2014, Amsterdam

Flow Cytometry Market worth $3.7 Billion in 2018
The report “Flow Cytometry Market by Technology (Cell & Bead-based), Products & Services (Reagents, Instruments, Software, & Accessories), Application (Research & Clinical), End User (Commercial Organizations & Diagnostics Laboratories) - Global Forecasts to 2018”analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and Rest of the world (RoW).

This report studies the global flow cytometry market over the forecast period of 2013-2018. The market is estimated at $2.3 billion in 2013 and is poised to grow at a CAGR of 10% from 2013-2018, to reach $3.7 billion by 2018.

On the basis of the type of technology, the flow cytometry market is segmented into cell-based, bead-based, and others. On the basis of products, the global flow cytometry market has been segmented into instruments, reagents and consumables, software, services, and accessories. In addition, based on the type of applications, the global flow cytometry market has been segmented into research, clinical, and industrial applications. Furthermore, based on the end-users, the global flow cytometry market has been segmented into commercial organizations, hospitals, academic institutes, medical schools, and clinical testing labs.

A number of factors such as the technological advancements in the flow cytometry instruments, fostering use of flow cytometry techniques in research activities, growing clinical trials, fostering prevalence of HIV and cancer, launch of new reagents for specific applications such as diagnostics, drug discovery, and the development of user friendly and intuitive software are driving the growth of the global flow cytometry market. Emerging markets such as China and India, development of high throughput flow cytometry, and fostering stem cells research, represent high growth opportunities for the market players.

As of 2013, North America (comprising the U.S. and Canada) held the largest share in the global flow cytometry market. This is attributed to the large number of ongoing researches, high adoption rate of new technologies, and infrastructural development in the U.S. However,the Asia-Pacific flow cytometry market is expected to grow at the highest CAGR of 16.1% from 2013 to 2018. A number of factors such asthe large patient population base, growing number of research initiatives, fostering awareness, increasing focus of global players, and increasing government supportare propelling the demand for the flow cytometry techniques in the Asia-Pacific region.

The flow cytometry market is a consolidated market with two major players namely, Becton, Dickinson and Company (U.S.) and Beckman Coulter, Inc. (U.S.) occupying more than 50% of the market. The other key players in the global flow cytometry market include Life Technologies Corporation (U.S.), EMD Millipore Corporation (U.S.), Miltenyi Biotech (Germany), Partec GmbH (Germany), Luminex Corporation (U.S.), and eBioscience, Inc. (U.S.).
Flow Cytometry Market - Global Forecasts to 2018

Flow Cytometry Market - Global Forecasts to 2018

Publish date : April 2014
Report code : ASDR-107012
Pages : 280

Flow Cytometry Market - Global Forecast to 2027

Flow Cytometry Market - Global Forecast to 2027

Publish date : August 2022
Report code : ASDR-608969
Pages : August 2022

ASDReports.com contact: S. Koomen

ASDReports.com / ASDMedia BV - Veemkade 356 - 1019HD Amsterdam - The Netherlands
P : +31(0)20 486 1286 - F : +31(0)20 486 0216

 back to News